HEADER TRANSFERASE/TRANSFERASE INHIBITOR 07-JAN-11 3Q96 TITLE B-RAF KINASE DOMAIN IN COMPLEX WITH A TETRAHYDRONAPHTHALENE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 446-727; COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF, P94, V-RAF MURINE SARCOMA VIRAL COMPND 6 ONCOGENE HOMOLOG B1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS DESIGN, OPTIMIZATION, POTENT, ORALLY BIOAVAILABLE, KEYWDS 2 TETRAHYDRONAPHTHALENE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.D.SINTCHAK,K.AERTGEERTS,J.YANO REVDAT 4 21-FEB-24 3Q96 1 REMARK REVDAT 3 08-NOV-17 3Q96 1 REMARK REVDAT 2 04-MAY-11 3Q96 1 JRNL REVDAT 1 23-MAR-11 3Q96 0 JRNL AUTH A.E.GOULD,R.ADAMS,S.ADHIKARI,K.AERTGEERTS,R.AFROZE, JRNL AUTH 2 C.BLACKBURN,E.F.CALDERWOOD,R.CHAU,J.CHOUITAR,M.O.DUFFEY, JRNL AUTH 3 D.B.ENGLAND,C.FARRER,N.FORSYTH,K.GARCIA,J.GAULIN, JRNL AUTH 4 P.D.GREENSPAN,R.GUO,S.J.HARRISON,S.C.HUANG,N.IARTCHOUK, JRNL AUTH 5 D.JANOWICK,M.S.KIM,B.KULKARNI,S.P.LANGSTON,J.X.LIU,L.T.MA, JRNL AUTH 6 S.MENON,H.MIZUTANI,E.PASKE,C.C.RENOU,M.REZAEI,R.S.ROWLAND, JRNL AUTH 7 M.D.SINTCHAK,M.D.SMITH,S.G.STROUD,M.TREGAY,Y.TIAN,O.P.VEIBY, JRNL AUTH 8 T.J.VOS,S.VYSKOCIL,J.WILLIAMS,T.XU,J.J.YANG,J.YANO,H.ZENG, JRNL AUTH 9 D.M.ZHANG,Q.ZHANG,K.M.GALVIN JRNL TITL DESIGN AND OPTIMIZATION OF POTENT AND ORALLY BIOAVAILABLE JRNL TITL 2 TETRAHYDRONAPHTHALENE RAF INHIBITORS. JRNL REF J.MED.CHEM. V. 54 1836 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 21341678 JRNL DOI 10.1021/JM101479Y REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 81.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 13851 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.233 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.288 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1381 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.18 REMARK 3 REFLECTION IN BIN (WORKING SET) : 831 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.03 REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE SET COUNT : 90 REMARK 3 BIN FREE R VALUE : 0.3300 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4075 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 78 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.95000 REMARK 3 B22 (A**2) : 0.95000 REMARK 3 B33 (A**2) : -1.91000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.536 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.376 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 21.366 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.897 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.835 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4250 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5760 ; 1.083 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 510 ; 5.023 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 177 ;36.607 ;23.785 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 745 ;18.515 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;17.593 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 637 ; 0.069 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3153 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2558 ; 0.403 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4129 ; 0.747 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1692 ; 0.660 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1631 ; 1.185 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS; U VALUES: REFINED INDIVIDUALLY REMARK 4 REMARK 4 3Q96 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-FEB-11. REMARK 100 THE DEPOSITION ID IS D_1000063351. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14022 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 81.730 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.20600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 0.66600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14.025% PEG 8000, 0.8M NP LITHIUM CL, REMARK 280 0.06M TRIS BASE, 0.04M TRIS CL, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.63200 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.01450 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.01450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 41.31600 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.01450 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.01450 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 123.94800 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.01450 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.01450 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 41.31600 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.01450 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.01450 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 123.94800 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 82.63200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 446 REMARK 465 SER A 447 REMARK 465 ASP A 448 REMARK 465 ALA A 598 REMARK 465 THR A 599 REMARK 465 VAL A 600 REMARK 465 LYS A 601 REMARK 465 SER A 602 REMARK 465 ARG A 603 REMARK 465 TRP A 604 REMARK 465 SER A 605 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 PHE A 610 REMARK 465 GLU A 611 REMARK 465 GLN A 612 REMARK 465 LEU A 613 REMARK 465 SER A 614 REMARK 465 GLY A 615 REMARK 465 GLN A 628 REMARK 465 ASP A 629 REMARK 465 LYS A 630 REMARK 465 LYS A 723 REMARK 465 ILE A 724 REMARK 465 HIS A 725 REMARK 465 ARG A 726 REMARK 465 SER A 727 REMARK 465 SER B 446 REMARK 465 SER B 447 REMARK 465 ASP B 448 REMARK 465 SER B 605 REMARK 465 GLY B 606 REMARK 465 SER B 607 REMARK 465 HIS B 608 REMARK 465 GLN B 609 REMARK 465 PHE B 610 REMARK 465 GLU B 611 REMARK 465 GLN B 612 REMARK 465 LEU B 613 REMARK 465 SER B 614 REMARK 465 LEU B 721 REMARK 465 PRO B 722 REMARK 465 LYS B 723 REMARK 465 ILE B 724 REMARK 465 HIS B 725 REMARK 465 ARG B 726 REMARK 465 SER B 727 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 462 NE CZ NH1 NH2 REMARK 470 PHE A 468 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 522 CG CD CE NZ REMARK 470 MET A 627 CG SD CE REMARK 470 LYS B 522 CG CD CE NZ REMARK 470 ARG B 558 NE CZ NH1 NH2 REMARK 470 LYS B 601 CG CD CE NZ REMARK 470 MET B 627 CG SD CE REMARK 470 GLN B 628 CG CD OE1 NE2 REMARK 470 ASP B 629 CG OD1 OD2 REMARK 470 LYS B 630 CG CD CE NZ REMARK 470 ARG B 691 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 709 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 463 -77.64 -81.94 REMARK 500 PHE A 468 -77.80 -88.40 REMARK 500 ARG A 509 80.53 -163.35 REMARK 500 ILE A 543 -64.98 -106.61 REMARK 500 GLU A 545 51.55 39.38 REMARK 500 ARG A 575 -11.82 82.12 REMARK 500 ASP A 576 51.21 -162.13 REMARK 500 LEU A 588 -52.62 -141.23 REMARK 500 ARG A 719 -71.79 -53.14 REMARK 500 LEU A 721 -61.02 -154.00 REMARK 500 PRO B 453 130.08 -36.77 REMARK 500 ARG B 575 -12.97 73.28 REMARK 500 ASP B 576 52.36 -155.40 REMARK 500 LEU B 588 -5.47 -144.94 REMARK 500 LEU B 597 -27.12 90.34 REMARK 500 ARG B 626 -8.21 -57.76 REMARK 500 SER B 679 1.41 -66.05 REMARK 500 LEU B 716 -70.78 -79.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0NF A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0NF B 1 DBREF 3Q96 A 446 727 UNP P15056 BRAF_HUMAN 446 727 DBREF 3Q96 B 446 727 UNP P15056 BRAF_HUMAN 446 727 SEQRES 1 A 282 SER SER ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE THR SEQRES 2 A 282 VAL GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR VAL SEQRES 3 A 282 TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS MET SEQRES 4 A 282 LEU ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN ALA SEQRES 5 A 282 PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG HIS SEQRES 6 A 282 VAL ASN ILE LEU LEU PHE MET GLY TYR SER THR LYS PRO SEQRES 7 A 282 GLN LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER SER SEQRES 8 A 282 LEU TYR HIS HIS LEU HIS ILE ILE GLU THR LYS PHE GLU SEQRES 9 A 282 MET ILE LYS LEU ILE ASP ILE ALA ARG GLN THR ALA GLN SEQRES 10 A 282 GLY MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS ARG SEQRES 11 A 282 ASP LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP LEU SEQRES 12 A 282 THR VAL LYS ILE GLY ASP PHE GLY LEU ALA THR VAL LYS SEQRES 13 A 282 SER ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU SER SEQRES 14 A 282 GLY SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG MET SEQRES 15 A 282 GLN ASP LYS ASN PRO TYR SER PHE GLN SER ASP VAL TYR SEQRES 16 A 282 ALA PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY GLN SEQRES 17 A 282 LEU PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE ILE SEQRES 18 A 282 PHE MET VAL GLY ARG GLY TYR LEU SER PRO ASP LEU SER SEQRES 19 A 282 LYS VAL ARG SER ASN CYS PRO LYS ALA MET LYS ARG LEU SEQRES 20 A 282 MET ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG PRO SEQRES 21 A 282 LEU PHE PRO GLN ILE LEU ALA SER ILE GLU LEU LEU ALA SEQRES 22 A 282 ARG SER LEU PRO LYS ILE HIS ARG SER SEQRES 1 B 282 SER SER ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE THR SEQRES 2 B 282 VAL GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR VAL SEQRES 3 B 282 TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS MET SEQRES 4 B 282 LEU ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN ALA SEQRES 5 B 282 PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG HIS SEQRES 6 B 282 VAL ASN ILE LEU LEU PHE MET GLY TYR SER THR LYS PRO SEQRES 7 B 282 GLN LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER SER SEQRES 8 B 282 LEU TYR HIS HIS LEU HIS ILE ILE GLU THR LYS PHE GLU SEQRES 9 B 282 MET ILE LYS LEU ILE ASP ILE ALA ARG GLN THR ALA GLN SEQRES 10 B 282 GLY MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS ARG SEQRES 11 B 282 ASP LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP LEU SEQRES 12 B 282 THR VAL LYS ILE GLY ASP PHE GLY LEU ALA THR VAL LYS SEQRES 13 B 282 SER ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU SER SEQRES 14 B 282 GLY SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG MET SEQRES 15 B 282 GLN ASP LYS ASN PRO TYR SER PHE GLN SER ASP VAL TYR SEQRES 16 B 282 ALA PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY GLN SEQRES 17 B 282 LEU PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE ILE SEQRES 18 B 282 PHE MET VAL GLY ARG GLY TYR LEU SER PRO ASP LEU SER SEQRES 19 B 282 LYS VAL ARG SER ASN CYS PRO LYS ALA MET LYS ARG LEU SEQRES 20 B 282 MET ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG PRO SEQRES 21 B 282 LEU PHE PRO GLN ILE LEU ALA SER ILE GLU LEU LEU ALA SEQRES 22 B 282 ARG SER LEU PRO LYS ILE HIS ARG SER HET 0NF A 1 39 HET 0NF B 1 39 HETNAM 0NF (2S)-N-[3-(2-AMINOPROPAN-2-YL)-5-(TRIFLUOROMETHYL) HETNAM 2 0NF PHENYL]-7-[(7-OXO-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN- HETNAM 3 0NF 4-YL)OXY]-1,2,3,4-TETRAHYDRONAPHTHALENE-2-CARBOXAMIDE FORMUL 3 0NF 2(C29 H29 F3 N4 O3) HELIX 1 1 THR A 491 ARG A 506 1 16 HELIX 2 2 LEU A 537 ILE A 543 1 7 HELIX 3 3 GLU A 549 LYS A 570 1 22 HELIX 4 4 LYS A 578 ASN A 580 5 3 HELIX 5 5 ALA A 621 MET A 627 1 7 HELIX 6 6 SER A 634 GLY A 652 1 19 HELIX 7 7 ASN A 661 GLY A 672 1 12 HELIX 8 8 ASP A 677 VAL A 681 5 5 HELIX 9 9 PRO A 686 LEU A 697 1 12 HELIX 10 10 LYS A 700 ARG A 704 5 5 HELIX 11 11 LEU A 706 SER A 720 1 15 HELIX 12 12 THR B 491 ARG B 506 1 16 HELIX 13 13 SER B 536 ILE B 543 1 8 HELIX 14 14 GLU B 549 LYS B 570 1 22 HELIX 15 15 GLU B 586 LEU B 588 5 3 HELIX 16 16 ALA B 621 ARG B 626 1 6 HELIX 17 17 SER B 634 GLY B 652 1 19 HELIX 18 18 ASN B 661 ARG B 671 1 11 HELIX 19 19 ASP B 677 VAL B 681 5 5 HELIX 20 20 PRO B 686 LEU B 697 1 12 HELIX 21 21 LYS B 700 ARG B 704 5 5 HELIX 22 22 LEU B 706 ALA B 718 1 13 SHEET 1 A 5 THR A 458 SER A 465 0 SHEET 2 A 5 THR A 470 LYS A 475 -1 O VAL A 471 N GLY A 464 SHEET 3 A 5 ASP A 479 MET A 484 -1 O MET A 484 N THR A 470 SHEET 4 A 5 ALA A 526 GLN A 530 -1 O THR A 529 N ALA A 481 SHEET 5 A 5 PHE A 516 SER A 520 -1 N GLY A 518 O VAL A 528 SHEET 1 B 3 GLY A 534 SER A 536 0 SHEET 2 B 3 ILE A 582 HIS A 585 -1 O LEU A 584 N SER A 535 SHEET 3 B 3 THR A 589 ILE A 592 -1 O THR A 589 N HIS A 585 SHEET 1 C 5 THR B 458 GLY B 466 0 SHEET 2 C 5 GLY B 469 LYS B 475 -1 O VAL B 471 N GLY B 464 SHEET 3 C 5 ASP B 479 MET B 484 -1 O VAL B 482 N TYR B 472 SHEET 4 C 5 ALA B 526 GLN B 530 -1 O ILE B 527 N LYS B 483 SHEET 5 C 5 PHE B 516 SER B 520 -1 N GLY B 518 O VAL B 528 SHEET 1 D 2 ILE B 582 HIS B 585 0 SHEET 2 D 2 THR B 589 ILE B 592 -1 O LYS B 591 N PHE B 583 CISPEP 1 LYS A 522 PRO A 523 0 11.57 CISPEP 2 LYS B 522 PRO B 523 0 5.01 SITE 1 AC1 15 ALA A 481 LYS A 483 GLU A 501 LEU A 505 SITE 2 AC1 15 LEU A 514 ILE A 527 THR A 529 GLN A 530 SITE 3 AC1 15 TRP A 531 CYS A 532 LEU A 567 HIS A 574 SITE 4 AC1 15 GLY A 593 ASP A 594 PHE A 595 SITE 1 AC2 15 VAL B 471 ALA B 481 LYS B 483 GLU B 501 SITE 2 AC2 15 VAL B 504 LEU B 514 GLN B 530 TRP B 531 SITE 3 AC2 15 CYS B 532 HIS B 574 PHE B 583 GLY B 593 SITE 4 AC2 15 ASP B 594 PHE B 595 ALA B 598 CRYST1 94.029 94.029 165.264 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010635 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010635 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006051 0.00000